Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Cholinesterase Inhibitor 6-Chlorotacrine - In Vivo Toxicological Profile and Behavioural Effects

View through CrossRef
Background: 6-chlorotacrine is a cholinesterase inhibitor showing good inhibitory potential, even better than parent compound tacrine, in vitro. Despite tacrine scaffold is broadly used for design and synthesis of novel compounds with anti-Alzheimer's potential, no in vivo effects have been investigated so far. Thus, basic toxicological and behavioural evaluation has been carried out throughout this study. Methods: Maximum tolerated dose (MTD) and median lethal dose (LD50) were assessed in BALB/c mice and Wistar rats. Behavioural effects were observed in rats performing the multiple T-maze test, the water maze test and the step-through passive avoidance test. All outcomes were compared with the effects of parent compound - tacrine. Results: The toxicity of 6-chlorotacrine was increased compared to tacrine with MTD 6.0/5.0 mg.kg-1 (i.m., male/female mice), 6.0/5.0 mg.kg-1 (i.p., male/female rats) and LD50 9.0 mg.kg-1 (male rats). At MTD doses, no histopathological changes and blood biochemistry abnormalities were observed except decreased plasma creatinine levels. 6-chlorotacrine showed good effects in the reversal of quinuclidinyl benzilate-induced amnesia. Best results were achieved at the dose of 1.8 mg.kg-1 (20% LD50) in the water maze test; the pro-cognitive effect was stronger than that of tacrine (5.2 mg.kg-1, 20% LD50). Other doses tested (0.9 mg.kg-1 and 2.7 mg.kg-1) showed similar effects as tacrine in the water maze, multiple T-maze and passive avoidance test. Conclusion: Observed effects predetermined 6-chlorotacrine as a potent parent compound for the synthesis of novel multifactorial drugs intended to the treatment of Alzheimer's disease. Even though 6- chlorotacrine showed in vivo beneficial effect with no signs of toxicity, further tests on the field of biochemistry and pharmacology are essential to disclose the exact mechanism of action, safety evaluation and the metabolic fate of the compound after the repeated administration.
Title: Cholinesterase Inhibitor 6-Chlorotacrine - In Vivo Toxicological Profile and Behavioural Effects
Description:
Background: 6-chlorotacrine is a cholinesterase inhibitor showing good inhibitory potential, even better than parent compound tacrine, in vitro.
Despite tacrine scaffold is broadly used for design and synthesis of novel compounds with anti-Alzheimer's potential, no in vivo effects have been investigated so far.
Thus, basic toxicological and behavioural evaluation has been carried out throughout this study.
Methods: Maximum tolerated dose (MTD) and median lethal dose (LD50) were assessed in BALB/c mice and Wistar rats.
Behavioural effects were observed in rats performing the multiple T-maze test, the water maze test and the step-through passive avoidance test.
All outcomes were compared with the effects of parent compound - tacrine.
Results: The toxicity of 6-chlorotacrine was increased compared to tacrine with MTD 6.
0/5.
0 mg.
kg-1 (i.
m.
, male/female mice), 6.
0/5.
0 mg.
kg-1 (i.
p.
, male/female rats) and LD50 9.
0 mg.
kg-1 (male rats).
At MTD doses, no histopathological changes and blood biochemistry abnormalities were observed except decreased plasma creatinine levels.
6-chlorotacrine showed good effects in the reversal of quinuclidinyl benzilate-induced amnesia.
Best results were achieved at the dose of 1.
8 mg.
kg-1 (20% LD50) in the water maze test; the pro-cognitive effect was stronger than that of tacrine (5.
2 mg.
kg-1, 20% LD50).
Other doses tested (0.
9 mg.
kg-1 and 2.
7 mg.
kg-1) showed similar effects as tacrine in the water maze, multiple T-maze and passive avoidance test.
Conclusion: Observed effects predetermined 6-chlorotacrine as a potent parent compound for the synthesis of novel multifactorial drugs intended to the treatment of Alzheimer's disease.
Even though 6- chlorotacrine showed in vivo beneficial effect with no signs of toxicity, further tests on the field of biochemistry and pharmacology are essential to disclose the exact mechanism of action, safety evaluation and the metabolic fate of the compound after the repeated administration.

Related Results

Reduced Serum Cholinesterase Activity Distinguishes Hepatic Encephalopathy From 48 Types of Human Diseases
Reduced Serum Cholinesterase Activity Distinguishes Hepatic Encephalopathy From 48 Types of Human Diseases
Abstract Background: Hepatic encephalopathy is a complication of central nervous systems due to liver failure-related brain inflammation. Less than half of patients sufferi...
Perbandingan Aktivitas Enzim Cholinesterase Serum dengan Metode Fotometri Teknik Sample Start dan Substrat Start
Perbandingan Aktivitas Enzim Cholinesterase Serum dengan Metode Fotometri Teknik Sample Start dan Substrat Start
Cholinesterase examination related to liver function and carried out by kinetic photometric method with two type reagent addition techniques, namely sample start and substrat start...
Behavioural and Cognitive Behavioural Training Interventions for Assisting Foster Carers in the Management of Difficult Behaviour
Behavioural and Cognitive Behavioural Training Interventions for Assisting Foster Carers in the Management of Difficult Behaviour
There is a lack of evidence about the efficacy of behavioural or cognitive‐behavioural training interventions for foster carers. The programmes are intended to assist foster carers...
Inhibitory Effects of Aspirin and Ibuprofen Overdose on Cholinesterase Activity: In Vivo and In Vitro Studies
Inhibitory Effects of Aspirin and Ibuprofen Overdose on Cholinesterase Activity: In Vivo and In Vitro Studies
Background: In recent years, it has been reported that long-term use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) may have protective effects against neurodegenerative disease...
In Silico Prediction of Toxicological and Pharmacokinetic Characteristics of Medicinal Compounds
In Silico Prediction of Toxicological and Pharmacokinetic Characteristics of Medicinal Compounds
Scientific relevance. Studies of the toxicological and pharmacokinetic properties of medicinal compounds are a crucial stage of preclinical research; unsatisfactory results may inv...
Plant Terpenoids as the Promising Source of Cholinesterase Inhibitors for Anti-AD Therapy
Plant Terpenoids as the Promising Source of Cholinesterase Inhibitors for Anti-AD Therapy
Plant-derived terpenes are the prolific source of modern drugs such as taxol, chloroquine and artemisinin, which are widely used to treat cancer and malaria infections. There are r...

Back to Top